Benchmark Upgrades Nektar Therapeutics (NKTR) to Buy

November 8, 2021 6:35 AM EST
Get Alerts NKTR Hot Sheet
Price: $3.49 +3.25%

Rating Summary:
    12 Buy, 11 Hold, 5 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 8 | Down: 9 | New: 24
Join SI Premium – FREE

Benchmark analyst Aydin Huseynov upgraded Nektar Therapeutics (NASDAQ: NKTR) from Hold to Buy with a price target of $20.00.

For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.

Shares of Nektar Therapeutics closed at $13.45 yesterday.

You May Also Be Interested In

Related Categories